News for Alcidion Group Limited (ALC.AX)

The ASX 200 closed down as war in the Middle East rattled…

Release Date: February 26, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Alcidion Gro

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NALC.AX - Alcidion Group LtdHalf Year 2025 Alcidion Group Ltd Earnings CallFeb 26, 2025 / 11:30

Healthcare technology developer Alcidion Group (ASX: ALC) has signed a 10-year contract with UK body North Cumbria Integrated Care NHS Foundation Trust

The ASX200 closed flat at 8,484 points. The Aussie bourse pared early…

Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities

Health software developer Alcidion Group (ASX: ALC) has signed a $4.5 million contract with Northern Adelaide Local Health Network (NALHN) for the use of

Revenue: $37.1 million, down 8% year-on-year.Annual Recurring Revenue (ARR): Up 6% year-on-year.Underlying EBITDA: Negative $3.4 million for the full year.Seco

A solid advance after a thumping fall on Thursday saw the Australian share market move back close to its record high but is a million miles away from

Alcidion Group (ASX: ALC) has been selected as the preferred supplier for a new electronic patient record (EPR) system being implemented by North Cumbria

Jan 30, 2023 / 12:00AM GMTKerstin Wahlqvist - Alcidion Group Limited - IR Manager Good morning, everyone, and a very warm welcome to this morning's presentation

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.90% to 6899.70.

Melbourne-based Alcidion Group's (ASX:ALC) shares have shot up on the release of its Q4 FY23 quarterly activities report.

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

The Nasdaq 100 index, a bellwether for global tech stocks, quietly entered into a technical bull market last week.

The cheapest profitable tech stock is the strife-prone EML Payments, which is trading on a 23-24 multiple of a mere 2.6 times.

Here’s a pick of revenue-generating healthcare stocks on the ASX which reported their half year earnings today.

The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.

Australian stocks have their sights on fresh 2023 highs after Wall Street…